Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
Clinical trial NCT00248157 · TERMINATED
Trial details
- NCT number
- NCT00248157
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2006-05-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.